Cladribine 10mg tablets
NHS hospitals in England used £41,200,705 of indicative cost of Cladribine 10mg tablets in the 12 months to April 2026, about 0.2% of all hospital medicines spend. That is up 71.9% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Cladribine 10mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Cladribine 10mg tablets most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| University College London Foundation Tr | £4,096,527 |
| Salford Royal Nhs Foundation Trust | £3,422,985 |
| University Hpls Coventry & Warwick Trust | £3,222,356 |
| University Hospital Southampton Nhs Ft | £2,284,720 |
| Lancashire T/Ing Hsp Nhs Foundation Trus | £1,924,406 |
| Cambridge Univ Hosp Nhs Foundation Trust | £1,860,941 |
| Barts Health Nhs Trust | £1,506,769 |
| St George's Univ Hosps Foundation Nhst | £1,347,084 |
| Western Sussex Hospitals Nhs Found Trust | £1,269,289 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £1,222,202 |
The primary-care picture
Cladribine is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Cladribine medicine page.